BioSig Technologies to present data from a study of its PURE EP system at Heart Rhythm 2021 in July

BioSig Technologies Inc (NASDAQ:BSGM) has announced that it will present an exhibit at the Heart Rhythm 2021 convention, held July 28-31 at the Boston Convention and Exhibition Center. The company’s executive leadership, and clinical, commercial and engineering teams will host a series of presentations at booth 849 that will showcase the latest clinical data and demonstrate the newest software features of its PURE EP System, the non-invasive Class 2 device that aims to drive procedural efficiency and efficacy in electrophysiology. BioSig will also host a series of invitation-only events that will feature physician user presentations. BioSig completed enrollments in its clinical trial in April 2021. During the 51-patient trial, the PURE EP System was used in all types of cardiac arrhythmia cases. Atrial fibrillation, the most common arrhythmia type, accounted for more than 40% of enrollments. READ: BioSig Technologies increases patient case goal to 1,500 procedures by end of 2021 “We are thrilled to join our peers at this year’s Heart Rhythm Society convention,” BioSig CEO Kenneth Londoner said in a statement. “Our company achieved meaningful progress over the past few months, driven by the increased technology usage of our PURE EP System across all installation sites. We have a packed schedule with the events surrounding our new clinical data and the latest insights from some of our largest physician users. With the convention now being able to operate at full capacity, we look forward to a very productive event that will set the tone for an impactful second half of the year.”. To date, 52 physicians have completed more than 940 patient cases with the PURE EP System across nine clinical sites, the company said, and it has been awarded FDA 510 clearance. BioSig commenced a targeted commercial launch in 2020 and completed commercial sales to St David’s HealthCare of Austin, Texas, an HCA Healthcare-owned hospital and the Mayo Foundation for Medical Education and Research. Heart Rhythm 2021 will convene more than 600 clinicians, scientists, researchers and innovators in the field of cardiac pacing and electrophysiology, who will lead over 100 sessions covering pacing, defibrillation, clinical arrhythmia management, ablation, pharmacology, genetics, basic science, health policy and more. Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com Follow him on Twitter @andrew_kessel